Early Access — free while we kick the tires
EdgarHawk

Charlton Henry L

EVP & Chief Commercial and Mkt

Officer
2 filings analyzed · 1 company · Latest 2025-11-13

Companies

Company Buys Sells Direction
INTUITIVE SURGICAL INC ISRG 0 32 Net selling

Activity

November 2025
2025-11-13 INTUITIVE SURGICAL INC ISRG
medium
Sell
13,731 shares
$7,963,980
Significance 6/10

EVP Charlton sells 13,731 shares ($7,963,980.00) in 5 transactions at $580.00 on 2025-11-12, reducing holdings 81.8%

Charlton Henry L, EVP & Chief Commercial and Marketing, executed 5 separate sales totaling 13,731 shares for $7,963,980.00 at $580.00 per share on November 12, 2025, reducing his holdings from 16,787 to 3,056 shares (an 81.8% reduction). The transaction occurred near the company's 52-week high of $610.45 and above the current price of $565.51. His prior 5 sales at ISRG all occurred on 2024-08-23 and registered negative or neutral 30-day returns; across his cross-ticker selling track record, the average 90-day return after sales was +13.1% with a 0.00% well-timed rate, indicating his prior sales have not preceded stock declines. At Intuitive's current valuation of 72.97 P/E and $200.5B market cap, with FY revenue growth of 17.2% and net income of $704.4M, the transaction's timing and magnitude relative to historical patterns and near-peak pricing warrant observation for investor context.

August 2024
2024-08-26 INTUITIVE SURGICAL INC ISRG
high
Sell
40,243 shares
$19,591,843
Significance 8/10

SVP Charlton Henry sold 40,243 shares for $19,591,842.70, reducing holdings 93.1% to 3,001 shares.

Charlton Henry L, SVP & Chief Commercial and Mkt, executed 13 separate sales totaling 40,243 shares for $19,591,842.70 at an average price of $486.84 on 2024-08-23. This sale represents a -93.1% reduction in his holdings, leaving him with only 3,001 shares post-transaction. The magnitude and near-complete liquidation of his position is notable given the company's recent strong performance: ISRG is up 8.6% over 30 days and 19.5% over 90 days, currently trading at $479.19 within its 52-week range of $258.49–$490.43. The stock trades at a P/E of 81.36 against a market cap of $170.3B with strong fundamentals (14.5% annual revenue growth and $526.9M net income last quarter). The sale occurred near the 52-week high of $490.43, minimizing downside exposure at peak valuation.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access